Complimentary Technical Snapshots on Envision Healthcare and Three More Long-Term Care Facilities Stocks

Stock Research Monitor: BKD, GEN, and KND

LONDON, UK / ACCESSWIRE / June 13, 2018 / If you want a free Stock Review on EVHC sign up now at www.wallstequities.com/registration. Today, WallStEquities.com takes a look at the Long-Term Care Facilities industry, which consists of various providers in community-based settings, quasi-institutions, and institutional facilities. Under evaluation are Brookdale Senior Living Inc. (NYSE: BKD), Envision Healthcare Corp. (NYSE: EVHC), Genesis Healthcare Inc. (NYSE: GEN), and Kindred Healthcare Inc. (NYSE: KND). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Brookdale Senior Living

Shares in Brentwood, Tennessee headquartered Brookdale Senior Living Inc. rose slightly by 0.88%, ending Tuesday's trading session at $9.13. The stock recorded a trading volume of 1.89 million shares. The Company's shares have gained 20.93% in the last month and 24.22% over the last three months. The stock is trading 24.35% and 0.21% above its 50-day and 200-day moving averages, respectively. Moreover, shares of the Company, which owns and operates senior living communities in the US, have a Relative Strength Index (RSI) of 83.25. Get the full research report on BKD for free by clicking below at:

www.wallstequities.com/registration/?symbol=BKD

Envision Healthcare

Nashville, Tennessee-based Envision Healthcare Corp.'s stock declined slightly by 0.13%, closing the day at $44.59. A total volume of 16.13 million shares was traded, which was above their three months average volume of 3.53 million shares. The Company's shares have advanced 5.36% in the past month and 4.38% in the previous three months. The stock is trading 11.17% and 15.23% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Envision Healthcare, which through its subsidiaries, provides various healthcare services in the US, have an RSI of 64.28.

On June 11^th, 2018, Envision Healthcare (EVHC) announced that it has entered into a definitive agreement to be acquired by global investment firm KKR, in an all-cash transaction for approximately $9.9 billion, including the assumption or repayment of debt. Under the terms of the agreement, which has been unanimously approved by EVHC's Board of Directors, KKR will acquire all of the outstanding shares of the former's common stock for $46.00 per share in cash, representing a 32% premium to EVHC's volume-weighted average share price from November 01^st, 2017. Access the free research report on EVHC now by signing up at:

www.wallstequities.com/registration/?symbol=EVHC

Genesis Healthcare

On Tuesday, shares in Kennett Square, Pennsylvania headquartered Genesis Healthcare Inc. recorded a trading volume of 887,759 shares, which was above their three months average volume of 685,520 shares. The stock ended the day 0.87% lower at $2.28. The Company's shares have advanced 39.02% in the past month, 45.22% in the previous three months, and 27.37% over the past year. The stock is trading above its 50-day and 200-day moving averages by 30.39% and 87.85%, respectively. Furthermore, shares of Genesis Healthcare, which together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the US, have an RSI of 60.18. Are you already registered with Wall St. Equities? Do so now for free, and get the report on GEN at:

www.wallstequities.com/registration/?symbol=GEN

Kindred Healthcare

Louisville, Kentucky headquartered Kindred Healthcare Inc.'s stock finished yesterday's session flat at $9.00. A total volume of 202,201 shares was traded. The Company's shares have advanced 1.12% in the last month. The stock is trading above its 50-day and 200-day moving averages by 0.59% and 8.02%, respectively. Additionally, shares of Kindred Healthcare, which provides healthcare services in the US, have an RSI of 56.12. Aspiring Member, please take a moment to register below for your free research report on KND at:

www.wallstequities.com/registration/?symbol=KND

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com

Phone number: 21 32 044 483

Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities